Year archive

GlaxoSmithkline Pharmaceuticals Ltd. — 2026 filings

All 83 regulatory filings released by GlaxoSmithkline Pharmaceuticals Ltd. (GLAXO) in 2026, sourced directly from the official regulator.

83 Filings

2026 Period

2026 filings (83)

Filing	Released	Lang
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-05-18	English
As per attachment Call Transcript	2026-05-18	English
Copy of Newspaper Publication Report Publication Announcement	2026-05-14	English
As per attachment Report Publication Announcement	2026-05-14	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-05-13	English
As per attachment Regulatory Filings	2026-05-13	English
Press Release Earnings Release FY 2026	2026-05-13	English
As per Attachment Earnings Release FY 2026	2026-05-13	English
Investor Presentation Investor Presentation	2026-05-13	English
Investor Presentation Investor Presentation	2026-05-13	English
As per attachment Interim / Quarterly Report FY 2026	2026-05-13	English
As per attachment Interim / Quarterly Report FY 2026	2026-05-13	English
As per attachment Interim / Quarterly Report FY 2026	2026-05-13	English
Shareholders meeting Interim / Quarterly Report FY 2026	2026-05-13	English
Outcome of Board Meeting Interim / Quarterly Report FY 2026	2026-05-13	English
As per attachment Interim / Quarterly Report FY 2026	2026-05-13	English
Record Date Interim / Quarterly Report FY 2026	2026-05-13	English
outcome of Meeting Interim / Quarterly Report FY 2026	2026-05-13	English
outcome of meeting Interim / Quarterly Report FY 2026	2026-05-13	English
Dividend Regulatory Filings	2026-05-13	English
Outcome of Meeting Earnings Release FY 2026	2026-05-13	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-05-07	English
Analyst Meet on 13th May 2026 Regulatory Filings	2026-05-07	English
Copy of Newspaper Publication Regulatory Filings	2026-04-22	English
Publication of special window for share transfer and Saksham Niveshak Campaign Regulatory Filings	2026-04-22	English
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial .... Regulatory Filings	2026-04-22	English
General Updates Regulatory Filings	2026-04-21	English
As per attachment Regulatory Filings	2026-04-21	English
Appointment Regulatory Filings	2026-04-21	English
Appointment of Mr. Vinay Subramanian Commercial Head, Oncology Regulatory Filings	2026-04-21	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-04-09	English
As per attachment Regulatory Filings	2026-04-09	English
Shareholders meeting Regulatory Filings	2026-04-08	English
As per attachment Regulatory Filings	2026-04-08	English
As per attachment Regulatory Filings	2026-04-08	English
Action(s) initiated or orders passed Regulatory Filings	2026-03-31	English
As per attachment Regulatory Filings	2026-03-31	English
Trading Window Regulatory Filings	2026-03-25	English
As per attachment Regulatory Filings	2026-03-25	English
Action(s) initiated or orders passed Regulatory Filings	2026-03-24	English
As per attachment Regulatory Filings	2026-03-24	English
Change in Management Regulatory Filings	2026-03-16	English
As per attachment Regulatory Filings	2026-03-16	English
Copy of Newspaper Publication Regulatory Filings	2026-03-11	English
As per attachment Regulatory Filings	2026-03-11	English
General Updates Regulatory Filings	2026-03-07	English
As per attachment Regulatory Filings	2026-03-07	English
Shareholders meeting Regulatory Filings	2026-03-07	English
As per attachment Regulatory Filings	2026-03-07	English
Action(s) initiated or orders passed Regulatory Filings	2026-03-07	English
As per attachment Regulatory Filings	2026-03-07	English
Change in Management Regulatory Filings	2026-03-02	English
Outcome of Board Meeting Regulatory Filings	2026-03-02	English
As per attachment Regulatory Filings	2026-03-02	English
As per attachment Regulatory Filings	2026-03-02	English
Action(s) initiated or orders passed Regulatory Filings	2026-02-28	English
As per attachment Regulatory Filings	2026-02-28	English
Action(s) initiated or orders passed Regulatory Filings	2026-02-23	English
As per attachment Regulatory Filings	2026-02-23	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-16	English
Transcript Regulatory Filings	2026-02-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-11	English
As per attachment Regulatory Filings	2026-02-11	English
Copy of Newspaper Publication Regulatory Filings	2026-02-10	English
As per attachment Regulatory Filings	2026-02-10	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-09	English
As attached Regulatory Filings	2026-02-09	English
Investor Presentation Regulatory Filings	2026-02-09	English
Presentation Regulatory Filings	2026-02-09	English
Press Release Regulatory Filings	2026-02-09	English
Press Release Regulatory Filings	2026-02-09	English
Outcome of Meeting Regulatory Filings	2026-02-09	English
Outcome of Meeting Regulatory Filings	2026-02-09	English
Outcome of Board Meeting Regulatory Filings	2026-02-09	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-03	English
As per attachment Regulatory Filings	2026-02-03	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-01-08	English
As per Attachment Regulatory Filings	2026-01-08	English
Board Meeting — Board Meeting Intimation Regulatory Filings	2026-01-06	English
Board Meeting — Financial Results Regulatory Filings	2026-01-06	English
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve take on record .... Regulatory Filings	2026-01-06	English
Action(s) initiated or orders passed Regulatory Filings	2026-01-01	English
As per attachment Regulatory Filings	2026-01-01	English

Filings by year

2026 83 filings
2025 234 filings
2024 295 filings
2023 262 filings
2022 148 filings
2021 130 filings
2020 131 filings
2019 141 filings
2018 49 filings
2017 36 filings
2016 29 filings
2015 26 filings
2014 21 filings
2013 10 filings
2012 4 filings
2011 4 filings
2010 1 filing